These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

637 related articles for article (PubMed ID: 30133783)

  • 1. The implication of CRISPR/Cas9 genome editing technology in combating human oncoviruses.
    Gilani U; Shaukat M; Rasheed A; Shahid M; Tasneem F; Arshad M; Rashid N; Shahzad N
    J Med Virol; 2019 Jan; 91(1):1-13. PubMed ID: 30133783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Application of CRISPR/Cas9-Based Gene Editing in HIV-1/AIDS Therapy.
    Xiao Q; Guo D; Chen S
    Front Cell Infect Microbiol; 2019; 9():69. PubMed ID: 30968001
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Harnessing CRISPR/Cas9 technology in cardiovascular disease.
    Rezaei H; Khadempar S; Farahani N; Hosseingholi EZ; Hayat SMG; Sathyapalan T; Sahebkar AH
    Trends Cardiovasc Med; 2020 Feb; 30(2):93-101. PubMed ID: 30935726
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Harnessing CRISPR/Cas 9 System for manipulation of DNA virus genome.
    Ebrahimi S; Teimoori A; Khanbabaei H; Tabasi M
    Rev Med Virol; 2019 Jan; 29(1):e2009. PubMed ID: 30260068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CRISPR-Cas9 in genome editing: Its function and medical applications.
    Khadempar S; Familghadakchi S; Motlagh RA; Farahani N; Dashtiahangar M; Rezaei H; Gheibi Hayat SM
    J Cell Physiol; 2019 May; 234(5):5751-5761. PubMed ID: 30362544
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CRISPR/Cas9-mediated genome editing of Epstein-Barr virus in human cells.
    Yuen KS; Chan CP; Wong NM; Ho CH; Ho TH; Lei T; Deng W; Tsao SW; Chen H; Kok KH; Jin DY
    J Gen Virol; 2015 Mar; 96(Pt 3):626-636. PubMed ID: 25502645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [CRISPR-Cas system as molecular scissors for gene therapy].
    Heinz GA; Mashreghi MF
    Z Rheumatol; 2017 Feb; 76(1):46-49. PubMed ID: 28124743
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CRISPR Editing Technology in Biological and Biomedical Investigation.
    White MK; Kaminski R; Young WB; Roehm PC; Khalili K
    J Cell Biochem; 2017 Nov; 118(11):3586-3594. PubMed ID: 28460414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prospects of CRISPR/Cas9 for HIV Elimination.
    Seclen E
    AIDS Rev; 2019; 21(2):109-111. PubMed ID: 31332399
    [No Abstract]   [Full Text] [Related]  

  • 10. Induced mutation and epigenetics modification in plants for crop improvement by targeting CRISPR/Cas9 technology.
    Khan MHU; Khan SU; Muhammad A; Hu L; Yang Y; Fan C
    J Cell Physiol; 2018 Jun; 233(6):4578-4594. PubMed ID: 29194606
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR-Cas9, A Promising Therapeutic Tool for Cancer Therapy: A Review.
    Akram F; Ikram Ul Haq ; Ahmed Z; Khan H; Ali MS
    Protein Pept Lett; 2020; 27(10):931-944. PubMed ID: 32264803
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Advances in application of clustered regularly interspaced short palindromic repeats (CRISPR)/CRISPR-associated 9 system in stem cells research].
    Sun SJ; Huo JH; Geng ZJ; Sun XY; Fu XB
    Zhonghua Shao Shang Za Zhi; 2018 Apr; 34(4):253-256. PubMed ID: 29690746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CRISPR-Cas9 system: A new-fangled dawn in gene editing.
    Gupta D; Bhattacharjee O; Mandal D; Sen MK; Dey D; Dasgupta A; Kazi TA; Gupta R; Sinharoy S; Acharya K; Chattopadhyay D; Ravichandiran V; Roy S; Ghosh D
    Life Sci; 2019 Sep; 232():116636. PubMed ID: 31295471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CRISPR/Cas9 System and its Research Progress in Gene Therapy.
    Liu W; Yang C; Liu Y; Jiang G
    Anticancer Agents Med Chem; 2019; 19(16):1912-1919. PubMed ID: 31633477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The potential application and challenge of powerful CRISPR/Cas9 system in cardiovascular research.
    Li Y; Song YH; Liu B; Yu XY
    Int J Cardiol; 2017 Jan; 227():191-193. PubMed ID: 27847153
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CRISPR-Cas9 for cancer therapy: Opportunities and challenges.
    Chen M; Mao A; Xu M; Weng Q; Mao J; Ji J
    Cancer Lett; 2019 Apr; 447():48-55. PubMed ID: 30684591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutagenesis and Genome Engineering of Epstein-Barr Virus in Cultured Human Cells by CRISPR/Cas9.
    Yuen KS; Chan CP; Kok KH; Jin DY
    Methods Mol Biol; 2017; 1498():23-31. PubMed ID: 27709566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CRISPR-Cas9: A Preclinical and Clinical Perspective for the Treatment of Human Diseases.
    Sharma G; Sharma AR; Bhattacharya M; Lee SS; Chakraborty C
    Mol Ther; 2021 Feb; 29(2):571-586. PubMed ID: 33238136
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Research progress of CRISPR-Cas9 system for gene therapy].
    Zhan C; Xia X
    Sheng Wu Gong Cheng Xue Bao; 2016 Jul; 32(7):861-869. PubMed ID: 29019208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [The application of CRISPR-Cas9 gene editing technology in viral infection diseases].
    Yin LJ; Hu SQ; Guo F
    Yi Chuan; 2015 May; 37(5):412-8. PubMed ID: 25998428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.